Seeing Is Believing

Currently out of the existing stock ratings of Seamus Fernandez, 30 are a HOLD (19.23%), 126 are a BUY (80.77%).
Analyst Seamus Fernandez, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 49.64% that have a potential upside of 33.16% achieved within 330 days.
Seamus Fernandez’s has documented 284 price targets and ratings displayed on 29 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CDTX, Cidara Therapeutics at 18-Nov-2025.
Analyst best performing recommendations are on ADGI (ADAGIO THERAPEUTICS).
The best stock recommendation documented was for ITCI (INTRACELLULAR TH) at 9/28/2016. The price target of $29 was fulfilled within 1 day with a profit of $13.35 (31.52%) receiving and performance score of 315.23.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$193
$-0.02 (-0.01%)
$178
5 years 7 months 9 days ago
(21-Apr-2020)
2/8 (25%)
$8.96 (4.87%)
125
Buy
$203
5 years 9 months 12 days ago
(18-Feb-2020)
1/2 (50%)
$20.22 (11.61%)
95
Hold
$203
$9.98 (5.17%)
$178
5 years 9 months 20 days ago
(10-Feb-2020)
5/16 (31.25%)
$4.87 (2.46%)
74
Hold
$188
5 years 10 months 8 days ago
(22-Jan-2020)
2/11 (18.18%)
$50.95 (37.18%)
254
Hold
$200
6 years 11 days ago
(19-Nov-2019)
2/11 (18.18%)
$73.92 (58.63%)
290
Which stock is Seamus Fernandez is most bullish on?
Which stock is Seamus Fernandez is most reserved on?
What Year was the first public recommendation made by Seamus Fernandez?